相关实验视频

Updated: Jul 24, 2025

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

治疗性化学抗原受体 (CAR) - - T 细胞:深入了解固体瘤的最新趋势和挑战

Keyvan Kheyrolahzadeh¹, Mohammad Reza Tohidkia², Ali Tarighatnia²

¹Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Nuclear Medicine, Faculty of Medicine, Imam Reza General Hospital, Tabriz University of Medical Sciences, Tabriz, Iran.

|July 8, 2023

概括

化学抗原受体 (CAR) -T细胞疗法对癌症有希望,但固体瘤仍然是一个挑战. 分子成像和细胞跟踪是克服障碍和改善CAR-T细胞传递以更好地治疗固体瘤的关键.

科学领域:

免疫治疗是一种免疫疗法.
在瘤学瘤学.
分子成像学分子成像学

背景情况:

细胞疗法,特别是嵌合抗原受体 (CAR) -T细胞疗法,在治疗血液性恶性瘤方面取得了成功.
将这些成功转化为固体瘤仍然是癌症治疗的重大挑战.
现有的细胞疗法平台需要改进以获得更广泛的疗效.

研究的目的:

审查CAR-T细胞在治疗固体和非固体瘤中的作用和最近的进展.
通过细胞疗法探索固体瘤治疗中的治疗障碍.
讨论分子成像和细胞跟踪在克服这些挑战中的应用.

主要方法:

对瘤学中CAR-T细胞疗法的当前文献的综述.
对CAR-T细胞的分子成像和细胞跟踪技术的分析.
讨论克服固体瘤治疗障碍的策略.

主要成果:

卡特-T细胞疗法在血液癌症中有效,但在固体瘤中面临局限性.
分子成像和细胞跟踪为CAR-T细胞行为和瘤微环境相互作用提供了洞察力.
新的策略正在开发中,以增强CAR-T细胞透和固体瘤中的持久性.

结论:

克服固体瘤中的治疗障碍对于推进细胞疗法至关重要.
分子成像和细胞跟踪是理解和改善CAR-T细胞治疗疗效的重要工具.
需要进一步研究新的策略,以将CAR-T细胞的成功转化为固体瘤治疗.

关键词:

适应性细胞疗法适应性细胞疗法在CART-T中,我们可以使用CAR-T.细胞疗法细胞疗法细胞追踪细胞追踪分子成像学分子成像学定子发射断层扫描 (PET) 是一种定子发射断层扫描.这是一个神经复杂的,theranostic.

更多相关视频

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Published on: June 14, 2024

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...